Lucite deal tombstone recognizing the merger of Adatptimmune and TCR2 Therapeutics. Both companies develop treatments that re-engineer immune cells to treat cancer. (23AKL209)
Lucite deal tombstone recognizing the merger of Adatptimmune and TCR2 Therapeutics. Both companies develop treatments that re-engineer immune cells to treat cancer. (23AKL209)
Crystal deal tombstone marking a follow-on offering by life sciences company Intelligent Bio Solutions The design incorporates the firm’s drug screening cartridge. (23AJH030)
Crystal financial tombstone marking a private placement by Midatech Pharma. The drug delivery technology firm is based in the UK. (23AJH028)
Crystal financial tombstone celebrating Series A funding for Lokavant. Based in New York, Lokavant provides a centralized data repository for clinical drug trials. (23AKL083)
Crystal deal toy, incorporating a 3D etching of a DNA strand, commemorating the merger of biotech companies Atrin Pharmaceuticals and Aprea Therapeutics. (22ALJ234)
Crystal financial tombstone recognizing the acquisition of Pathology Consultants. The life sciences company is based in Greenville, South Carolina. (23AZH099)
Lucite deal tombstone marking a registered direct offering of stock by AlloVir. The clinical-stage cell therapy firm is based in Waltham, Massachusetts. (22AZH231)
Lucite tombstone recognizing the acquisition of GeneTx BioTherapeutics. GeneTx has focused on a therapy for Angelman syndrome, a rare neurogenic disease. (22ALJ280)
